Jon Campisi Apr. 23, 2012, 8:39am

Personal injury attorneys from the Lundy Law firm in Philadelphia have filed a mass tort claim in the city’s Court of Common Pleas on behalf of an out-of-state plaintiff who alleges injuries that arose out of taking the drug Reglan during a two-decade period.

The plaintiff in the case, Shannon Millet, who resides in Taylorsville, Utah, claims to have ingested Reglan, or its generic form, metoclopramide, from 1990 until 2010.

As a result of taking the drug, Millet claims to have suffered from Tardive Dyskinesia, tremors, Macroglossia, and an aggravation of pre-existing conditions.

Millet also allegedly suffered emotional distress and financial loss as a result of the drug-related injuries.

The brand name defendants in the lawsuit are Wyeth Pharmaceuticals, Schwarz Pharma, Alaven Pharmaceutical, Wockhardt USA, Morton Grove Pharmaceuticals and Baxter Healthcare Corporation.

The complaint also names 37 generic drug manufacturer defendants, including, but not limited to, Teva Pharmaceuticals USA, Pliva Inc., Barr Pharmaceuticals, Duramed Pharmaceuticals, The Harvard Drug Group, Beach Products, United Research Laboratories, Mutual Pharmaceutical Company, and Schering Corporation.

The lawsuit, which was jointly filed April 19 at the Philadelphia Court of Common Pleas by Philadelphia attorneys L. Leonard Lundy and Jordan Schlossberg, and Salt Lake City, Utah lawyers Robert B. Hart and Christopher R. Hart, accuses the defendants of various counts of strict liability and negligence, as well as fraud and intentional misrepresentation, constructive fraud, breach of implied warranties, unfair and deceptive trade practices, unjust enrichment, civil conspiracy, and gross negligence and malice.

The plaintiff demands compensatory and punitive damages, disgorgement of profits and restitution of all costs, attorney’s fees, pre-and-post-judgment interest and other litigation costs.

The suit was filed as a short form complaint in the master Reglan/metoclopramide litigation.

Reglan, and its generic equivalent, which are designed to treat gastrointestinal problems, has been the ongoing subject of mass tort litigation due to the drug’s alleged neurological side effects.


The case number is 120402237.


More News